Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
57
57 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- NGI226Phase 21 trial
Novartis · Achilles Tendinopathy
- NIO752Phase 21 trial
Novartis · Progressive Supranuclear Palsy, Corticobasal Degeneration, Frontotemporal Lobar Degeneration
- PKN605Phase 21 trial
Novartis · Atrial Fibrillation
- RHH646Phase 21 trial
Novartis · Osteoarthritis, Knee
- sabatolimabMBG453Phase 21 trial
Novartis · Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic
- spartalizumabPDR001Phase 21 trial
Novartis · Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic
- YMI024Phase 21 trial
Novartis · Coronary Artery Disease
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.